Formation and degradation of N-oxide venlafaxine during ozonation and biological post-treatment.

Sci Total Environ

Hydro-Chemistry and Water Research Center, Earth Sciences, Tel Aviv University, Tel Aviv 69978, Israel.

Published: April 2018

While ozonation is considered an efficient treatment to eliminate trace organic compounds (TrOCs) from secondary wastewater effluents, the presence and persistence of transformation products (TPs) resulting from ozonation of TrOCs is a major concern that should be assessed prior to effluent discharge to the environment. Venlafaxine (VLX), an environmentally relevant tertiary amine-containing TrOC, was chosen as the model for this study. TP analysis confirmed that the lone electron pair of the non-protonated amine are the predominant site of oxidant attack, and therefore strongly affected by pH value and VLX speciation. N-oxide VLX (NOV), the primary ozone-induced TP, was formed and degraded simultaneously during ozonation of VLX-containing secondary effluent and reached a maximum yield of 0.44 to 0.85 (NOV-to-VLX ratio), depending on pH and hydroxyl (OH) radical presence. Rate constants for the reaction of NOV with ozone (3.1×10Ms) and OH radicals (5.3×10Ms) were determined. A simple kinetic model was developed to fit the kinetics of formation and degradation of NOV during ozonation in secondary effluents, based on a known ozone-reaction kinetic equation. The biodegradability of NOV (degradation rate of 39%) was significantly lower than that of the parent compound (VLX, 92%) after 71days, as evaluated by modified Zahn-Wellens tests, suggesting that N-oxide products are not better removed than the parent compound in a simulated biological post-treatment, which may even result in partial reformation of the parent compound. Lessons learned from this study were supported by a pilot-scale demonstration at the Shafdan wastewater-treatment plant, confirming the presence of NOV after ozonation and its persistence in biological post-treatment. Removal of such persistent TP will require higher dosages or promotion of OH-radicals during ozonation. Nevertheless, further assessment of the toxicity of persistent TPs relative to the parent compound is needed for complete evaluation of concerned TPs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2017.11.133DOI Listing

Publication Analysis

Top Keywords

parent compound
16
biological post-treatment
12
formation degradation
8
nov ozonation
8
ozonation
7
nov
5
degradation n-oxide
4
n-oxide venlafaxine
4
venlafaxine ozonation
4
ozonation biological
4

Similar Publications

Tetrahydroberberrubine improves hyperlipidemia by activating the AMPK/SREBP2/PCSK9/LDL receptor signaling pathway.

Eur J Pharmacol

January 2025

State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology, College of Pharmacy, and Department of Cardiology, the Second Affiliated Hospital, Harbin Medical University, Harbin 150081, China; State Key Labratoray-Province Key Laboratories of Biomedicine-Pharmaceutics of China, and Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin 150081, China; Research Unit of Noninfectious Chronic Diseases in Frigid Zone (2019RU070), Chinese Academy of Medical Sciences, Harbin 150081, China. Electronic address:

Hyperlipidemia is a major risk factor for hypertension, coronary heart disease, diabetes and stroke, triggering an intensified research efforts into its prevention and treatment. Tetrahydroberberrubine (THBru) is a derivative of berberine (BBR) that has been shown to have higher bioavailability and lower toxicity compared to its parent compound. However, its impact on hyperlipidemia has not been fully explored.

View Article and Find Full Text PDF

Tattooing is a popular form of body art that has evolved from ancient times into being part of modern society. The understanding of biotransformation processes of coloring tattoo pigments in human skin is limited although skin reactions to tattoos with unknown culprits occur. Electrochemistry coupled to mass spectrometry (EC-MS) has widely been used as a tool for a purely instrumental approach to simulating the enzymatic biotransformation of xenobiotics.

View Article and Find Full Text PDF

Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) is an uncommon hereditary form of rickets characterised by chronic renal phosphate loss and impaired bone mineralisation. This results from compound heterozygous or homozygous pathogenic variants in ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), a key producer of extracellular inorganic pyrophosphate (PPi) and an inhibitor of fibroblast growth factor23 (FGF23). ENPP1 deficiency impacts FGF23 and increases its activity.

View Article and Find Full Text PDF

We report the application of organoiridium complexes as catalytic agents for the detoxification of biogenic reactive aldehyde species (RASP), which are implicated in the pathogenesis of neurodegenerative disorders. We show that Ir complexes functionalized with phosphonium cations localize selectively in the mitochondria and have better cellular retention compared to that of their parent Ir species. In a cell model for Parkinsonism, the mitochondria-targeted iridium catalysts exhibited superior cell protecting abilities and longer-lasting effects (up to 6 d) than conventional RASP scavengers, which failed to be effective beyond 24 h.

View Article and Find Full Text PDF

The design of dualsteric/bitopic receptor ligands as compounds capable of simultaneously interacting with both the orthosteric and an allosteric binding site has gained importance to achieve enhanced receptor specificity and minimize off-target effects. In this work, we reported the synthesis and biological evaluation of a new series of compounds, namely, the series, obtained by chemically combining the CB1R ago-positive allosteric modulators (PAM) with the cannabinoid receptors (CBRs) orthosteric agonist . Therefore, compounds were designed as dualsteric/bitopic ligands for CB1R with the aim of obtaining stronger CB1R agonists or ago-PAMs, with improved receptor subtype selectivity and reduction of central side effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!